Combining Resources to Create the Premier, Patient-Focused Renal Solutions Provider POMPANO BEACH, Fla. and NEW YORK, March 5, 2024 /PRNewswire/ -- Patient Care America ('PCA') announces that it recently completed the acquisition of Lyfebulb Holdings Inc., ('Lyfebulb') an online digital platform that empowers people living with chronic illnesses to thrive through education, innovation, and connectivity.

2024年3月5日，佛罗里达州蓬帕诺海滩（PompanoBeach）和纽约（NEW YORK）联合资源创建了首屈一指的、以患者为中心的肾脏解决方案提供商——美国患者护理协会（Patient Care America，简称“PCA”）宣布，它最近完成了对Lyfebull Holdings Inc.（“Lyfebull”）的收购，Lyfebull是一个在线数字平台，它使慢性病患者能够通过教育、创新，和连通性。

'We are thrilled to welcome the Lyfebulb team into the Patient Care America family. Lyfebulb has established itself as a trusted resource for those living with serious health conditions, such as chronic kidney disease, diabetes and transplants,' stated Phil Keough, CEO of Patient Care America. 'This partnership will help broaden our range of patient centered services to create leading comprehensive solutions that enhance the health and well-being of our patients.'

“我们很高兴欢迎Lyfebulb团队加入美国患者护理大家庭。美国患者护理首席执行官菲尔·基奥（PhilKeough）表示，Lyfebull已成为那些患有严重健康状况（如慢性肾脏病、糖尿病和移植）的人的可靠资源这种合作关系将有助于扩大我们以患者为中心的服务范围，创造领先的综合解决方案，增进患者的健康和福祉。”

The Lyfebulb management team, led by co-founder and former CEO Karin Hehenberger, MD, PhD, will remain in place and lead Lyfebulb's patient-engagement services. Dr. Hehenberger will operate as President of Lyfebulb, a Patient Care America company, and will also take on the role of Chief Medical Officer of PCA.

由联合创始人兼前首席执行官Karin Hehenberger（医学博士）领导的Lyfebull管理团队将继续留任，并领导Lyfebull的患者参与服务。Hehenberger博士将担任Lyfebull（一家美国患者护理公司）的总裁，并将担任PCA的首席医疗官。

'Lyfebulb is excited to join forces with Patient Care America to continue to positively impact patients in the chronic illness space. We have spent over a decade identifying and validating the need for patient connectivity, education and innovation in diabetes and kidney disease, with a specific focus on the optimal management of kidney transplants,' added Dr.

“Lyfebull很高兴与美国患者护理协会（Patient Care America）携手合作，继续对慢性病领域的患者产生积极影响。我们花了十多年的时间来确定和验证糖尿病和肾脏疾病患者连通性、教育和创新的需求，特别关注肾脏移植的最佳管理。

Hehenberger. 'With the additional resources and capabilities offered by our new colleagues, we can accelerate the implementation of our accumulated knowledge through new digital tools, services and offerings.'Lyfebulb will continue to operate its digital platforms, www.TransplantLyfe.com and www.CancerLyfe.com, as a Patient Care America company.

海恩伯格。”有了新同事提供的额外资源和能力，我们可以通过新的数字工具、服务和产品加速实施我们积累的知识。”Lyfebull将继续运营其数字平台www.transplalyfe.com和www.CancerLyfe.com，作为一家美国患者护理公司。

Financial terms of the transaction are not disclosed.About Patient Care AmericaPatient Care America, a leading national provider of nutritional therapies for malnourished dialysis patients, is a healthcare service organization comprised of dedicated professionals committed to delivering the highest quality patient care to achieve optimal therapeutic outcomes.

交易的财务条款未披露。关于患者护理美国患者护理美国是营养不良透析患者营养治疗的领先国家供应商，是一家由专业人士组成的医疗服务组织，致力于提供最高质量的患者护理，以实现最佳治疗效果。

Its dedicated, multidisciplinary team of pharmacists, nurses, dietitians, and other health care professionals provide NutriRite® Intradialytic Parenteral Nutrition (IDPN) and NutriRite Home™ Intraperitoneal Nutrition (IPN) formulas, helping enhance quality of life for all patients through innovative and patient-centered approaches.

其专业的多学科药剂师、护士、营养师和其他医疗保健专业人员团队提供NutriRite®透析内肠外营养（IDPN）和NutriRite Home™腹膜内营养（IPN）配方，通过创新和以患者为中心的方法帮助提高所有患者的生活质量。